Colin Kelly is a postbaccalaureate fellow in the Early Translation Branch (ETB) within NCATS’ Division of Preclinical Innovation. As a member of the Guanine Team, he works directly with Jonathan H. Shrimp, Ph.D., focusing on molecular probe development, in vitro pharmacology, assay development for high-throughput screening in microplates, CRISPR-Cas9 knock-in and other ETB projects. Prior to joining NCATS, he spent four years working as an undergraduate project leader in the Hare Laboratory Group — also known as the Duke Canine Cognition Center — where his research focused on the cognitive abilities of canines, specifically in relation to object permanence.
Kelly earned his Bachelor of Science in biology with minors in chemistry and finance from Duke University.
Kelly’s primary project is related to characterizing the anti-cancer activity of nutrient-targeted enzymes in leukemia cell lines. He also assists with various projects related to assay development and in vitro pharmacology.